Investment
Features
FeesSafety
Academy
More
Pluang+

China's 2026 gold imports may double 2025 levels, while silver prices face key test amid dollar strength.

Market News
28 Sep 2026
Kitco
View Source
Neutral
China's 2026 gold imports may double 2025 levels, while silver prices face key test amid dollar strength.

China's gold imports in 2026 have already surpassed 2025 totals, reaching 1,141 tonnes in eight months, driven by strong investment demand despite high prices. If this pace continues, imports could hit around 1,700 tonnes, the highest this decade. Meanwhile, silver prices are at a critical level due to a stronger U.S. dollar and rising Treasury yields, with potential for either a rally or continued decline. Additionally, India’s weak monsoon may reduce gold demand during its festival season, and Indonesia is pushing to integrate private gold holdings into formal financial markets to boost liquidity.

China's gold import outlook and silver price test provide context for market activity on Pluang. For readers following these developments, here is Pluang's market snapshot as of Sep 28, 2026 21:51 WIB: Of 150 priced US stocks tradable on Pluang, 34 rose and 116 fell today. Notable movers include GFI (Gold Fields Limited) at USD 35.48 with a 1-day change of -12.13% and a typical hold time of 49 days, RBLX (Roblox Corp) at USD 42.70 down 8.05%, and NU (Nu Holdings Ltd) at USD 12.53 down 7.80%.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
2 hours ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
3 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
3 hours ago
Salesforce trades cheaper with steady growth; ServiceNow grows faster but at higher valuation.

Salesforce trades cheaper with steady growth; ServiceNow grows faster but at higher valuation.

Salesforce and ServiceNow both reported strong AI-driven bookings, with ServiceNow growing revenue 24% and trading at 27x forward earnings, while Salesforce grew 10.8% at about 14x forward earnings. ServiceNow leads in AI product innovation and rapid...

Market News
Bullish
4 hours ago
The Hanover Insurance earns top spots on TIME and Forbes best companies lists again in 2026

The Hanover Insurance earns top spots on TIME and Forbes best companies lists again in 2026

The Hanover Insurance Group has been recognized on TIME's World's Best Companies list for the fourth year and Forbes' America's Best Insurance Companies list for the sixth year. These honors reflect the company's strong business strategy, excellent c...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App